Literature DB >> 16189249

Association of testosterone, insulin-like growth factor-I, and C-reactive protein with metabolic syndrome in Chinese middle-aged men with a family history of type 2 diabetes.

Peter C Y Tong1, Chung-Shun Ho, Vincent T F Yeung, Maggie C Y Ng, Wing-Yee So, Risa Ozaki, Gary T C Ko, Ronald C W Ma, Emily Poon, Norman N Chan, Christopher W K Lam, Juliana C N Chan.   

Abstract

CONTEXT: Age-related declines in testosterone and IGF-I are associated with deposition of visceral fat, a component of the metabolic syndrome (MES).
OBJECTIVE: Testosterone and IGF-I may interact with familial disposition to diabetes mellitus to increase the association with MES.
DESIGN: We conducted a cross-sectional cohort study.
SETTING: The study was conducted in a university teaching hospital.
SUBJECTS: Study subjects included 179 middle-aged men with a family history of diabetes (FH) (aged 39.1 +/- 8.1 yr) and 128 men without FH (aged 43.8 +/- 8.5 yr). MAIN OUTCOME MEASURES: Clinical characteristics, frequency of MES using the World Health Organization criteria with Asian definitions of obesity (body mass index > or = 25 kg/m2), and serum levels of total testosterone, IGF-I, and high-sensitive C-reactive protein (hs-CRP) were measured.
RESULTS: Men with FH had higher frequency of MES than those without FH [39.1 vs. 23.4% (P = 0.004)]. On multivariate analysis, smoking (former and current smokers), low total testosterone, and IGF-I but elevated hs-CRP levels explained 35% of the MES variance in men with FH. The frequency of MES increased with declining tertiles of total testosterone and IGF-I but increasing tertiles of hs-CRP. After adjustment for age and smoking history, subjects with all three risk factors had a 13-fold increase in risk association with MES compared with those without hormonal and inflammatory risk factors. These risk associations were not found in men without FH in whom only smoking (ex and current) and low total testosterone level were independent predictors for MES, which explained 14% of the variance.
CONCLUSIONS: Clustering of FH, hormonal abnormalities, and high hs-CRP is associated with MES in Chinese middle-aged men.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189249     DOI: 10.1210/jc.2005-0228

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Authors:  David R Clemmons
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06       Impact factor: 4.741

Review 2.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  The relation of metabolic syndrome according to five definitions to cardiovascular risk factors--a population-based study.

Authors:  Cheng-Chieh Lin; Chiu-Shong Liu; Chia-Ing Li; Wen-Yuan Lin; Ming-May Lai; Tsann Lin; Pei-Chia Chang; Yih-Dar Lee; Ching-Chu Chen; Chih-Hsueh Lin; Chuan-Wei Yang; Chih-Yi Hsiao; Walter Chen; Tsai-Chung Li
Journal:  BMC Public Health       Date:  2009-12-23       Impact factor: 3.295

Review 4.  Diabetes and its comorbidities--where East meets West.

Authors:  Alice P S Kong; Gang Xu; Nicola Brown; Wing-Yee So; Ronald C W Ma; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2013-05-28       Impact factor: 43.330

5.  The prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran.

Authors:  Mohammad Reza Mirzaei; Massoud Amini; Ashraf Aminorroaya
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

6.  Intrauterine growth restriction perturbs nucleosome depletion at a growth hormone-responsive element in the mouse IGF-1 gene.

Authors:  Robert A McKnight; Christian C Yost; Xing Yu; Julia E Wiedmeier; Christopher W Callaway; Ashley S Brown; Robert H Lane; Camille M Fung
Journal:  Physiol Genomics       Date:  2015-10-20       Impact factor: 4.297

7.  Testosterone and metabolic syndrome: The link.

Authors:  Ranabir Salam; Achouba Singh Kshetrimayum; Reetu Keisam
Journal:  Indian J Endocrinol Metab       Date:  2012-03

Review 8.  Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence.

Authors:  Kitty Kit Ting Cheung; Andrea On Yan Luk; Wing Yee So; Ronald Ching Wan Ma; Alice Pik Shan Kong; Francis Chun Chung Chow; Juliana Chung Ngor Chan
Journal:  J Diabetes Investig       Date:  2014-11-03       Impact factor: 4.232

Review 9.  Testosterone, diabetes mellitus, and the metabolic syndrome.

Authors:  Richard F Spark
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 2.862

10.  Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies.

Authors:  Judith S Brand; Maroeska M Rovers; Bu B Yeap; Harald J Schneider; Tomi-Pekka Tuomainen; Robin Haring; Giovanni Corona; Altan Onat; Marcello Maggio; Claude Bouchard; Peter C Y Tong; Richard Y T Chen; Masahiro Akishita; Jourik A Gietema; Marie-Hélène Gannagé-Yared; Anna-Lena Undén; Aarno Hautanen; Nicolai P Goncharov; Philip Kumanov; S A Paul Chubb; Osvaldo P Almeida; Hans-Ulrich Wittchen; Jens Klotsche; Henri Wallaschofski; Henry Völzke; Jussi Kauhanen; Jukka T Salonen; Luigi Ferrucci; Yvonne T van der Schouw
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.